Email this article THE EFFICACY OF PLASMA SORPTION (LIVER SUPPORT) IN LIVER FAILURE IN PATIENTS WITH MECHANICAL JAUNDICE
- Authors: Fomin A.M.1, Lobakov A.I.1, Titova G.V.1, Zakharov Y.I.1
-
Affiliations:
- Moscow Regional Research and Clinical Institute
- Issue: No 40 (2015)
- Pages: 101-108
- Section: ARTICLES
- URL: https://almclinmed.ru/jour/article/view/113
- DOI: https://doi.org/10.18786/2072-0505-2015-40-101-108
- ID: 113
Cite item
Full Text
Abstract
Background: New methods of extracorporeal hemocorrection and detoxification in liver failure of patients with mechanical jaundice need an assessment of their efficacy and safety, especially with consideration of baseline hypocoagulation and systemic heparin administration.
Aim: To assess the efficacy of plasma sorption with Plasorba BR-350 in liver failure patients with mechanical jaundice.
Materials and methods: The study was conducted in 12 patients (aged from 47 to 67 years) with mechanical jaundice as a consequence of biliary obstruction (choledocholithiasis). At baseline, total bilirubin level was from 101.9 to 611 µmol/l. Extracorporeal hemocorrection (The Liver Support procedures) was carried out with the Octo Nova device (Asahi Kasei Medical, Japan) and Plasorba BR-350 sorbent based on were measured prior, during and upon termination of a procedure. Results: By the end of the procedure, there was a trend towards decrease in total bilirubin level by 18.6 ± 3.8% (p = 0.13), conjugated bilirubin by 14.6 ± 6.4% (p = 0.06), unconjugated bilirubin by 16.9 ± 9.8% (p = 0.17), and aspartate aminotransferase by 18.67 ± 2.3% (p = 0.077), with a statistically significant decrease in alanine aminotransferase 17.07 ± 3.4% (p = 0.002). Other blood chemistry parameters did not show any changes. There were no changes in hemoglobin and platelets throughout the study and no negative changes in the international normalized ratio, activated partial thromboplastin time, and fibrinogen, prothrombin, and anti-thrombin III levels. During hemosorption procedures no bleeding complications were noted in any patient.
Conclusion: Plasma sorption (Liver Support) allows for correction of hyperbilirubinemia in liver failure patients with mechanical jaundice without a significant influence on other blood chemistry parameters. Due to the absence of bleeding complications during the procedure and lack of chang- es in the coagulogram after the procedure, this method of the liver support can be recommended for patients with high bilirubin levels in mechanical jaundice during preparation for surgical treatment for the bile ducts obstruction and postoperatively.
About the authors
A. M. Fomin
Moscow Regional Research and Clinical Institute
Email: galinatitova@mail.ru
Fomin Aleksandr Mikhaylovich – MD, PhD, Professor, Head of Department of Surgical Hemocorrection and Detoxification Russian Federation
A. I. Lobakov
Moscow Regional Research and Clinical Institute
Email: galinatitova@mail.ru
Lobakov Aleksandr Ivanovich – MD, PhD, Professor, Head of Department of Abdominal Surgery; Chair of Surgery, Postgraduate Training Faculty Russian Federation
G. V. Titova
Moscow Regional Research and Clinical Institute
Author for correspondence.
Email: galinatitova@mail.ru
Titova Galina Vasil'evna – Junior Research Fellow, Department of Surgical Hemocorrection and Detoxification Russian Federation
Yu. I. Zakharov
Moscow Regional Research and Clinical Institute
Email: galinatitova@mail.ru
Zakharov Yuriy Ivanovich – PhD, Leading Research Fellow, Department of Abdominal Surgery Russian Federation
References
- Ивашкин ВТ. Болезни печени и желчевыводящих путей: руководство для врачей. М.: М-Вести; 2005. 416 с.
- Гальперин ЭИ, Семендяева МН, Неклюдова ЕА. Недостаточность печени. М.: Медицина; 1978. 328 с.
- Натальский АА, Тарасенко СВ, Зайцев ОВ, Песков ОД. Современные представления о печеночной недостаточности в хирургии. Российский медико-биологический вестник имени академика И.П. Павлова. 2014;(4):138–47.
- Иоффе ИВ, Потеряхин ВП. Печеночная недостаточность у больных с механической желтухой неопухолевого генеза. Український журнал клінічної та лабораторної медицини. 2009;4(3):130–2.
- Фомин АМ, Ладенкова ЛС, Бабушкин ВЮ. Селективная плазмофильтрация при меха нической желтухе. Эфферентная терапия. 2013;19(1):108–9.
- Бокерия ЛА, Ярустовский МБ, ред. Руководство по экстракорпоральному очищению крови. М.: НЦССХ им. А.Н. Бакулева РАМН; 2009. 468 с.
- Хорошилов СЕ, Половников СГ, Асташев ВЛ, Скворцов СВ, Кудряшов СК, Хазанов АИ. Острая (молниеносная) и острая/хроническая печеночная недостаточность: возможности коррекции альбуминовым диализом на аппарате MARS. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2007;17(2):57–62.
- Еремеева ЛФ, Ямпольский АФ. Экстракорпоральные методы лечения у пациентов с печеночно-клеточной недостаточностью. Актуальные проблемы транспортной медицины. 2010;(4):139–49.
- Соколов АА, Захаров МВ, Бельских АН. Возможности селективной плазмофильтрации при заболеваниях печени. Эфферентная терапия. 2013;19(1):103–4.
- Хорошилов СЕ, Гранкин ВИ, Скворцов СВ, Пономарев СВ, Кудряшов СК, Хазанов АИ. Лечение острой печеночной и печеночно-почечной недостаточности с применением альбуминового диализа на аппарате MARS. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2006;16(2):49–54.
- Adani GL, Lorenzin D, Currò G, Sainz-Barriga M, Comuzzi C, Bresadola V, Avellini C, Baccarani U. Selective bilirubin removal by plasma treatment with Plasorba BR-350 for early cholestatic graft dysfunction. Transplant Proc. 2007;39(6):1904–6.
Supplementary files
